Response to letter regarding article, "rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the bypass angioplasty revascularization investigation 2 diabetes (BARI 2D) trial"

Richard G. Bach; Maria Mori Brooks; Manuel Lombardero; Saul Genuth; Thomas W. Donner; Alan Garber; Laurence Kennedy; E. Scott Monrad; Rodica Pop-Busui; Sheryl F. Kelsey; Robert L. Frye

doi:10.1161/CIRCULATIONAHA.113.008033

Response to letter regarding article, "rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the bypass angioplasty revascularization investigation 2 diabetes (BARI 2D) trial"

Richard G. Bach, Maria Mori Brooks, Manuel Lombardero, Saul Genuth, Thomas W. Donner, Alan Garber, Laurence Kennedy, E. Scott Monrad, Rodica Pop-Busui, Sheryl F. Kelsey, Robert L. Frye

Medicine

Research output: Contribution to journal › Letter › peer-review

3 Scopus citations

Original language	English (US)
Pages (from-to)	e460-e461
Journal	Circulation
Volume	129
Issue number	16
DOIs	https://doi.org/10.1161/CIRCULATIONAHA.113.008033
State	Published - Apr 22 2014

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine
Physiology (medical)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1161/CIRCULATIONAHA.113.008033

Cite this

Bach, R. G., Brooks, M. M., Lombardero, M., Genuth, S., Donner, T. W., Garber, A., Kennedy, L., Monrad, E. S., Pop-Busui, R., Kelsey, S. F., & Frye, R. L. (2014). Response to letter regarding article, "rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the bypass angioplasty revascularization investigation 2 diabetes (BARI 2D) trial". Circulation, 129(16), e460-e461. https://doi.org/10.1161/CIRCULATIONAHA.113.008033

Response to letter regarding article, "rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the bypass angioplasty revascularization investigation 2 diabetes (BARI 2D) trial". / Bach, Richard G.; Brooks, Maria Mori; Lombardero, Manuel et al.
In: Circulation, Vol. 129, No. 16, 22.04.2014, p. e460-e461.

Research output: Contribution to journal › Letter › peer-review

Bach, RG, Brooks, MM, Lombardero, M, Genuth, S, Donner, TW, Garber, A, Kennedy, L, Monrad, ES, Pop-Busui, R, Kelsey, SF & Frye, RL 2014, 'Response to letter regarding article, "rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the bypass angioplasty revascularization investigation 2 diabetes (BARI 2D) trial"', Circulation, vol. 129, no. 16, pp. e460-e461. https://doi.org/10.1161/CIRCULATIONAHA.113.008033

Bach RG, Brooks MM, Lombardero M, Genuth S, Donner TW, Garber A et al. Response to letter regarding article, "rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the bypass angioplasty revascularization investigation 2 diabetes (BARI 2D) trial". Circulation. 2014 Apr 22;129(16):e460-e461. doi: 10.1161/CIRCULATIONAHA.113.008033

@article{09117a7a41424dac9f4bfe68c660486a,

title = "Response to letter regarding article, {"}rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the bypass angioplasty revascularization investigation 2 diabetes (BARI 2D) trial{"}",

author = "Bach, {Richard G.} and Brooks, {Maria Mori} and Manuel Lombardero and Saul Genuth and Donner, {Thomas W.} and Alan Garber and Laurence Kennedy and Monrad, {E. Scott} and Rodica Pop-Busui and Kelsey, {Sheryl F.} and Frye, {Robert L.}",

year = "2014",

month = apr,

day = "22",

doi = "10.1161/CIRCULATIONAHA.113.008033",

language = "English (US)",

volume = "129",

pages = "e460--e461",

journal = "Circulation",

issn = "0009-7322",

publisher = "Lippincott Williams and Wilkins",

number = "16",

}

TY - JOUR

T1 - Response to letter regarding article, "rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the bypass angioplasty revascularization investigation 2 diabetes (BARI 2D) trial"

AU - Bach, Richard G.

AU - Brooks, Maria Mori

AU - Lombardero, Manuel

AU - Genuth, Saul

AU - Donner, Thomas W.

AU - Garber, Alan

AU - Kennedy, Laurence

AU - Monrad, E. Scott

AU - Pop-Busui, Rodica

AU - Kelsey, Sheryl F.

AU - Frye, Robert L.

PY - 2014/4/22

Y1 - 2014/4/22

UR - http://www.scopus.com/inward/record.url?scp=84899108231&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899108231&partnerID=8YFLogxK

U2 - 10.1161/CIRCULATIONAHA.113.008033

DO - 10.1161/CIRCULATIONAHA.113.008033

M3 - Letter

C2 - 24753557

AN - SCOPUS:84899108231

SN - 0009-7322

VL - 129

SP - e460-e461

JO - Circulation

JF - Circulation

IS - 16

ER -

Response to letter regarding article, "rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the bypass angioplasty revascularization investigation 2 diabetes (BARI 2D) trial"

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this